DR. ZEHRA KAPADIA MD NPI 1417930876

NPI Information

  • NPI: 1417930876
  • Provider Name: DR. ZEHRA KAPADIA, MD
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1140 WESTMONT DR
    SUITE 200
    HOUSTON, TX
    ZIP 77015
  • Phone: (713) 330-3000

Map and Directions

Get Directions

NPI Details

DR. Zehra Kapadia, MD is a medical oncology internal medicine in Houston, TX with 28 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. DR. Zehra Kapadia, MD NPI is 1417930876. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

1140 WESTMONT DR
SUITE 200
HOUSTON, TX
ZIP 77015-363
Phone: (713) 330-3000
Fax: (713) 453-8300

The NPI 1417930876 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Blood test, clotting time (HCPCS:85610)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Automated urinalysis test (HCPCS:81003)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)

The enumeration date for this NPI number is 11/21/2005 and was last updated on 10/19/2011.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & OncologyM0451TEXASNo
2207RX0202XInternal MedicineMedical OncologyM0451TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1186447201MEDICAIDTEXAS
28J8532MEDICARE PINTEXAS
38W4996OTHERTEXASBCBS
4I59834MEDICARE UPIN
5186447202MEDICAIDTEXAS
6TXB134246MEDICARE PINTEXAS
7P00442835MEDICARE PINTEXAS
8TXB118049MEDICARE PINTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.